Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-11

Clinical Trial Update: I-STAND R21: Reducing Sedentary Time in Older Adults [NA]

View source ↗

Summary

The I-STAND R21 trial evaluating strategies to reduce sedentary time in older adults has completed, with results posted on May 11, 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Obesity, Sedentary Lifestyle | NA | Status: COMPLETED | Results posted: 2018-05-11